Armata Pharmaceuticals, Inc. (ARMP) stock
ARMPNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.66−0.33 (-11.04%)
Close on Nov 17, 2026Market cap $98.90MP/E –Yield –
Armata Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Armata Pharmaceuticals's price to book ratio was 4.2× on Oct 31, 2023, against 2.0× a year earlier. Over the last 5 years it ranged from 0.8× to 6.5×, with a median of 2.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Oct 31, 2023 | 4.2× | +3.3 |
| 2022 | Dec 30, 2022 | 1.0× | −4.8 |
| 2021 | Dec 31, 2021 | 5.8× | +3.5 |
| 2020 | Dec 31, 2020 | 2.3× | +0.5 |
| 2019 | Dec 31, 2019 | 1.8× | +1.0 |
| 2018 | Dec 31, 2018 | 0.8× | −1.2 |
| 2017 | Dec 29, 2017 | 1.9× | +1.4 |
| 2016 | Dec 30, 2016 | 0.5× | −2.5 |
| 2015 | Dec 31, 2015 | 3.0× | −15.0 |
| 2014 | Dec 31, 2014 | 18.0× | – |
See a number that looks wrong?